[Evaluation of the impact of a letter of information about metoclopramide].
Jean-Pastor
M J
MJ
Rodor
F
F
Nguyen
N
N
Gambini
D
D
Locatelli
C
C
Obedia
E
E
D018492:Dopamine Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D004358:Drug Therapy / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects* / Q000627:therapeutic use; D010820:Physicians; D011795:Surveys and Questionnaires
D018492:Dopamine Antagonists; D008787:Metoclopramide